The study analyzed patients from Rochester, Minn.-based Mayo Clinic from Feb. 27 to July 22. It involved 8,889 patients who received Johnson & Johnson’s vaccine and 88,898 unvaccinated patients.
Sixty of the vaccinated patients tested positive for COVID-19, while 2,236 of the unvaccinated patients tested positive. Infection data was determined by PCR tests.
The researchers concluded that the vaccine led to a 3.73-fold reduction in infections.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
